June 30, 2020 / 9:56 PM / 11 days ago

BRIEF-Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients

June 30 (Reuters) - Corcept Therapeutics Inc:

* CORCEPT THERAPEUTICS INITIATES PHASE 3 TRIAL OF RELACORILANT PLUS NAB-PACLITAXEL IN PATIENTS WITH METASTATIC PANCREATIC CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below